Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2102

1.

A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Hermesse J, Biver S, Jansen N, Lenaerts E, De Patoul N, Vynckier S, Coucke P, Scalliet P, Nickers P.

Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5. Epub 2009 Nov 10.

PMID:
19899007
[PubMed - indexed for MEDLINE]
2.

Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.

Hermesse J, Biver S, Jansen N, Lenaerts E, Nickers P.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):269-76. doi: 10.1016/j.ijrobp.2009.05.046. Epub .

PMID:
19775833
[PubMed - indexed for MEDLINE]
3.

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.

Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M 3rd, Phillips T.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8.

PMID:
10705005
[PubMed - indexed for MEDLINE]
4.

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.

Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, Gustafson G, Ye H, Martinez A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):204-12. doi: 10.1016/j.ijrobp.2010.10.009. Epub 2010 Dec 16.

PMID:
21167653
[PubMed - indexed for MEDLINE]
5.

Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.

Pieters BR, van de Kamer JB, van Herten YR, van Wieringen N, D'Olieslager GM, van der Heide UA, Koning CC.

Radiother Oncol. 2008 Jul;88(1):46-52. doi: 10.1016/j.radonc.2008.02.023. Epub 2008 Apr 2.

PMID:
18378028
[PubMed - indexed for MEDLINE]
6.

Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.

Martinez AA, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M, Jaffray DA, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1226-34.

PMID:
11483333
[PubMed - indexed for MEDLINE]
7.

Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.

Dogan N, King S, Emami B, Mohideen N, Mirkovic N, Leybovich LB, Sethi A.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1480-91.

PMID:
14630288
[PubMed - indexed for MEDLINE]
8.

Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer.

Tao Y, Lefkopoulos D, Ibrahima D, Bridier A, Polizzi Mdel P, Wibault P, De Crevoisier R, Arriagada R, Bourhis J.

Acta Oncol. 2008;47(3):442-50. Epub 2007 Sep 28.

PMID:
17906985
[PubMed - indexed for MEDLINE]
9.
10.

Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.

Mavroidis P, Ferreira BC, Shi C, Lind BK, Papanikolaou N.

Phys Med Biol. 2007 Jul 7;52(13):3817-36. Epub 2007 May 31.

PMID:
17664579
[PubMed - indexed for MEDLINE]
11.

Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.

Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):752-9.

PMID:
15183478
[PubMed - indexed for MEDLINE]
12.

The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.

Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1383-91.

PMID:
15275723
[PubMed - indexed for MEDLINE]
13.

Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.

Georg D, Hopfgartner J, Gòra J, Kuess P, Kragl G, Berger D, Hegazy N, Goldner G, Georg P.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):715-22. doi: 10.1016/j.ijrobp.2013.11.241.

PMID:
24521685
[PubMed - indexed for MEDLINE]
14.

Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation.

Caudrelier JM, Morgan SC, Montgomery L, Lacelle M, Nyiri B, Macpherson M.

Radiother Oncol. 2009 Jan;90(1):99-105. doi: 10.1016/j.radonc.2008.09.028. Epub 2008 Nov 1.

PMID:
18977546
[PubMed - indexed for MEDLINE]
15.

Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.

Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.

Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22.

PMID:
18215434
[PubMed - indexed for MEDLINE]
16.

Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.

Konishi K, Yoshioka Y, Isohashi F, Sumida I, Kawaguchi Y, Kotsuma T, Adachi K, Morimoto M, Fukuda S, Inoue T.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1003-7. doi: 10.1016/j.ijrobp.2008.12.051. Epub 2009 Apr 3.

PMID:
19345517
[PubMed - indexed for MEDLINE]
17.

A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.

Aydogan B, Mundt AJ, Smith BD, Mell LK, Wang S, Sutton H, Roeske JC.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):266-73.

PMID:
16618581
[PubMed - indexed for MEDLINE]
18.

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.

Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71.

PMID:
16168838
[PubMed - indexed for MEDLINE]
19.

192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.

Nickers P, Thissen B, Jansen N, Deneufbourg JM.

Radiother Oncol. 2006 Jan;78(1):47-52. Epub 2005 Oct 10.

PMID:
16216365
[PubMed - indexed for MEDLINE]
20.

Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy.

Perna L, Fiorino C, Cozzarini C, Broggi S, Cattaneo GM, De Cobelli F, Mangili P, Di Muzio N, Calandrino R.

Radiother Oncol. 2009 Oct;93(1):57-63. doi: 10.1016/j.radonc.2009.04.004. Epub 2009 May 4.

PMID:
19410316
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk